Patients with severe COVID-19 are known to have increased vascular inflammation characterized by increased expression of lung endothelial ICAM-1 and VCAM-1, which facilitate the infiltration of inflammatory cells into the lung tissue (Birnhuber et al., 2021). The gene discussed is VCAM1; the disease is COVID-19.